Teleflex Incorporated (TFX)
NYSE: TFX · Real-Time Price · USD
180.14
+2.88 (1.62%)
Dec 26, 2024, 4:00 PM EST - Market closed
Teleflex Revenue
Teleflex had revenue of $764.38M in the quarter ending September 29, 2024, with 2.41% growth. This brings the company's revenue in the last twelve months to $3.03B, up 2.27% year-over-year. In the year 2023, Teleflex had annual revenue of $2.97B with 6.57% growth.
Revenue (ttm)
$3.03B
Revenue Growth
+2.27%
P/S Ratio
2.80
Revenue / Employee
$208,678
Employees
14,500
Market Cap
8.37B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 2.97B | 183.45M | 6.57% |
| Dec 31, 2022 | 2.79B | -18.52M | -0.66% |
| Dec 31, 2021 | 2.81B | 272.41M | 10.74% |
| Dec 31, 2020 | 2.54B | -58.21M | -2.24% |
| Dec 31, 2019 | 2.60B | 146.98M | 6.00% |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
| Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Walgreens Boots Alliance | 147.66B |
| Henry Schein | 12.50B |
| The Ensign Group | 4.11B |
| Jazz Pharmaceuticals | 3.99B |
| Chemed | 2.38B |
| HealthEquity | 1.15B |
| Repligen | 633.51M |
| Ascendis Pharma | 365.19M |
TFX News
- 5 weeks ago - Teleflex to Present at the 36th Annual Piper Sandler Healthcare Conference - GlobeNewsWire
- 7 weeks ago - Teleflex to Present at the Jefferies London Healthcare Conference - GlobeNewsWire
- 2 months ago - Teleflex Incorporated (TFX) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Teleflex beats quarterly profit estimates on robust medical devices demand - Reuters
- 2 months ago - Teleflex Announces Quarterly Dividend - GlobeNewsWire
- 2 months ago - Teleflex Reports Third Quarter Financial Results and Full Year 2024 Outlook - GlobeNewsWire
- 2 months ago - First Patient Enrolled in Teleflex's Barrigel™ Rectal Spacer Trial for Post Radical Prostatectomy Radiation Therapy (PPRT) - GlobeNewsWire
- 2 months ago - Teleflex launches next-generation Arrow™ VPS Rhythm™ DLX Device and NaviCurve™ Stylet in Canada - GlobeNewsWire